⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 4, 2024Open Access

Figure S1 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer

Dongshi Chen Kaylee Ermine Yi-Jun Wang Xiaojun Chen Xinyan Lu Peng Wang Donna B. Stolz Jian Yu Lin Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Figure S1. No association was found between RIP1 and MLKL expression and CRC patient survival.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e75dd0b6db6435876d4bac https://doi.org/10.1158/1535-7163.25337725.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S4 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer2024
2Figure S3 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer2024
3Figure S7 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer2024
4Figure S8 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer2024
5Figure S5 from PUMA/RIP3 Mediates Chemotherapy Response via Necroptosis and Local Immune Activation in Colorectal Cancer2024